Home
MyCare - Patients: View your medical records securely online here.
Log in Learn More

Cardiology

« Previous 12 Next »
Viewing Page 1 of 2 | Showing Results 1 - 10 of 14
Prospective, Non-Randomized Clinical Study to Establish the Safety, Performance and Effectiveness of the Ingevity Active and Passive Fixation Pace/Sense Leads
8/22/2014
Mark Hamer, MD

Clinical trial to establish the safety and effectiveness of a new Pacemaker lead called Ingevity. Sponsor: Boston Scientific.

Absorb IV is a prospective, randomized (1:1, Absorb BVS to XIENCE), single-blind, multi-center study
8/22/2014
Thomas Stuver, MD

Compare treatment of lesions (narrowing) in the coronary arteries using bioresorbable stents versus metallic drug-eluting stents. Absorb IV is a...

Mosaic° ULTRATm Bioprosthesis Aortic Valve, Model 305U
Dr. Ronald Kirshner

Purpose: Subjects requiring replacement of aortic heart valve with the FDA approved Medtronic Mosaic® UltraTM bioprsthetic heart valve. 6 month f/u...

Evaluation of long term treatment of a combination pill of clopidogrel and prilosec compared to clopidogrel alone
Dr. Thomas Stuver

Subjects requiring long term treatment of dual anti-platelet therapy are randomized either to new combination pill of clopidogrel and prilosec or...

Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL)
Dr. Thomas Stuver

Subjects with history of or current high blood pressure and known renal artery stenosis are randomized either to renal stent plus medical therapy...

Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D
8/22/2014
Parag Patel, MD

A multi-center, prospective, randomized, double-blind study to assess the safety and effectiveness of the automatic optimization algorithm as...

CAPTIVATE: CAPTure Information Via Automatic Threshold Evaluation; a Prospective, Non-Randomized, Multi-Center, IDE Clinical Study
8/22/2014
Thomas Stuver, MD

This study will evaluate the PaceSafe Right Ventricular Autothreshold (RVAT) and Left Ventricular Autothreshold (LVAT) features for patients...

A Randomized, Open-Label, Multi-Center, Active-Controlled, Parellel Group Study to Determine the Efficacy and Safety of the REG-1 Anti-Coagulation System Compared to Bivalirudin in Subjects Undergoing Percutaneous Coronary Intervention
8/22/2014
Thomas Stuver, MD

To compare a non-reversible anticoagulant (Bival) with a reversible anti-coagulant system, featuring an anti-coagulant study drug and its reversal...

« Previous 12 Next »